GLP-1 Receptor Agonists in Orthopaedic Surgery: Implications for Perioperative Care and Outcomes
Authors:
- Rahul RamanathanRRRahul Ramanathan
- Joon Y. LeeJLJoon Y. Lee
- Jonathan F. DaltonJDJonathan F. Dalton
- Ryan T. LinRLRyan T. Lin
- Isaac LeeILIsaac Lee
- Christopher GonzalezCGChristopher Gonzalez
- Jeremy D. ShawJSJeremy D. Shaw
- Gregory D. SchroederGSGregory D. Schroeder
- Christopher K. KeplerCKChristopher K. Kepler
- Michael SpitnaleMSMichael Spitnale
- Alexander R. VaccaroAVAlexander R. Vaccaro
- Alexandra S. GabrielliAGAlexandra S. Gabrielli
Open Access
- 10 July 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (16) , 1879-1886
Abstract
➢ Glucagon-like peptide-1 (GLP-1) receptor agonists are a promising tool for preoperative weight loss in the patient who is undergoing orthopaedic surgery and has concomitant obesity and type-2 diabetes mellitus. ➢ With regard to the perioperative management of GLP-1 receptor agonists for the orthopaedic surgeon, the American Society of Anesthesiologists (ASA) recommends withholding daily-dose GLP-1 therapy on the day of the elective surgical procedure and withholding weekly-dose therapy for the week prior to the procedure. ➢ The ASA recommends postponing surgery or proceeding with “full stomach precautions” if the patient undergoing an orthopaedic procedure and taking GLP-1 therapy exhibits gastrointestinal symptoms on the day of the elective procedure. ➢ In the trauma setting, patients taking GLP-1 therapy should proceed with the surgical procedure at the discretion of the surgeon with full stomach precautions or a preoperative point-of-care gastric ultrasound. ➢ GLP-1 receptor agonists show the potential for disease modification in osteoarthritis and osteoporosis.Keywords
This publication has 81 references indexed in Scilit:
- Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor AgonistsThe Journal of Clinical Pharmacology, 2024
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor AgonistsAdvances in Therapy, 2021
- Bone Fractures in Children and Young Adults With Type 1 Diabetes: Age Distribution, Fracture Location, and the Role of Glycemic ControlJournal of Bone and Mineral Research, 2020
- Bariatric Surgery and Time to Total Joint Arthroplasty: Does It Affect Readmission and Complication Rates?Obesity Surgery, 2017
- Nutrition Counseling in Clinical PracticeJAMA, 2017
- Surgical Risks and Costs of Care are Greater in Patients Who Are Super Obese and Undergoing THAClinical Orthopaedics and Related Research, 2016
- Body mass index predicts perioperative complications following orthopaedic trauma surgery: an ACS-NSQIP analysisEuropean Journal of Trauma and Emergency Surgery, 2016
- Relationship Between Bariatric Surgery and Bone Mineral Density: a Meta-analysisObesity Surgery, 2015
- Changes in Bone Metabolism in Morbidly Obese Patients After Bariatric Surgery: A Meta-AnalysisObesity Surgery, 2015